NRSNW
NeuroSense Therapeutics Ltd. - Warrant (NRSNW)
$21
About NeuroSense Therapeutics Ltd. - Warrant (NRSNW)
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Details
Daily high
$0.36
Daily low
$0.21
Price at open
$0.35
52 Week High
$1.00
52 Week Low
$0.15
Market cap
--
Dividend yield
0.00%
Volume
11,760
Avg. volume
986
P/E ratio
--
NeuroSense Therapeutics Ltd. - Warrant News
Details
Daily high
$0.36
Daily low
$0.21
Price at open
$0.35
52 Week High
$1.00
52 Week Low
$0.15
Market cap
--
Dividend yield
0.00%
Volume
11,760
Avg. volume
986
P/E ratio
--